AbstractHIVInternational Workshop on HIV Pediatrics 2021Viral Load Coverage and Suppression Around COVID-19: EswatiniView Abstract
AbstractHIVInternational Workshop on HIV Pediatrics 2021Adherence to Antiretroviral Therapy among Children Living with HIV in North-Central Nigeria: a Qualitative Evaluation of Barriers and Facilitators among CaregiversView Abstract
AbstractHIVInternational Workshop on HIV Pediatrics 2021Adolescent and caregiver perspectives on an enhanced adherence counseling intervention for youth with suspected HIV treatment failure in KenyaView Abstract
AbstractHIVInternational Workshop on HIV Pediatrics 2021Challenges in the effective treatment of infant HIV undermine the potential impact of birth testing and neonatal ART: preliminary results from the LIFE trial in Mozambique and TanzaniaView Abstract
AbstractHIVInternational Workshop on HIV Pediatrics 2021Successful Scale- Up of Optimal Antiretroviral Regimens and Improvement in Viral Suppression for Children and Adolescents Living with HIV Amidst COVID 19 Pandemic In KenyaView Abstract
AbstractHIVInternational Workshop on HIV Pediatrics 2021The road to success is paved with dolutegravir: Dolutegravir treatment success among in children and adolescents living with HIV (CALHIV) at the Baylor Tanzania Centres of Excellence.View Abstract
AbstractHIVInternational Workshop on HIV Pediatrics 2021HIV Drug Resistance Patterns Among Highly Treatment-Experienced Children, Adolescents and Young Adults in Sub-Saharan AfricaView Abstract
AbstractHIVInternational Workshop on HIV Pediatrics 2021Early Trends in HIV Drug Resistance Mutations Among Pediatric and Young Adult (0-24 years) Clients in Sub-Saharan AfricaView Abstract
AbstractHIVInternational Workshop on HIV Pediatrics 2021Mutations associated with ineffectiveness of HIV-1 protease inhibitors in children in Abidjan, Côte d'IvoireView Abstract
AbstractHIVInternational Workshop on HIV Pediatrics 2021Neuropsychiatric manifestations and sleep disturbances in children and adolescents randomised to dolutegravir-based ART vs standard-of-care in the ODYSSEY trialView Abstract
AbstractHIVInternational Workshop on HIV Pediatrics 2021Effect of dolutegravir on folate and vitamin B12 status among HIV-infected children and adolescents in the ODYSSEY trialView Abstract
AbstractHIVInternational Workshop on HIV Pediatrics 2021Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Fumarate (E/C/F/TAF) on Bone Safety Parameters in Children and Adolescents Living with HIVView Abstract
